Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide
<p>Abstract</p> <p>Background</p> <p>Hypoxia-inducible factor-1α (HIF-1α), a critical transcription factor to reduced O<sub>2 </sub>availability, has been demonstrated to be extensively involved in tumor survival, aggressive progression, drug resistance and...
Main Authors: | Li Zheng, Tong Lin-Jiang, Dai Mei, Feng Jian-Ming, Chen Yi, Jiang Yi, Yu Bing, Luo Zhi-Guo, Zhou Zhao-Li, Li Yuan-Chao, Ding Jian, Miao Ze-Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/268 |
Similar Items
-
1H NMR-Based Metabolomics Reveals the Antitumor Mechanisms of Triptolide in BALB/c Mice Bearing CT26 Tumors
by: Cheng Li, et al.
Published: (2019-10-01) -
In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration
by: Huahui Zeng, et al.
Published: (2020-01-01) -
A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under Hypoxia
by: Emmanuel Datan, et al.
Published: (2020-09-01) -
Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II).
by: Ying Wang, et al.
Published: (2011-01-01) -
Inhibition of RNA polymerase III transcription by Triptolide attenuates colorectal tumorigenesis
by: Xia Liang, et al.
Published: (2019-05-01)